Is Adiponectin Elevation Associated with Left Atrial Remodeling and Impaired Mechanical Functions? (a Speckle Tracking Study)

Objectives    Recent studies demonstrated that elevated adiponectin levels predicted an increased risk of atrial fibrillation (AF) and stroke; however, a causal relationship is yet to be unknown. Reduced left atrium (LA) functions detected by two-dimensional echocardiographic speckle tracking (2D-STE) can predict AF development. We aimed to investigate the relationship between adiponectin level and LA functions in hypertensive and diabetic patients at high risk for incident AF.
Material and methods    The study consisted of 80 hypertensive diabetic patients. All patients underwent echocardiography, and venous blood samples were taken. The relationship between adiponectin levels and LA functions was analyzed.
Results    We divided patients into two groups according to the mean adiponectin level (13.63 ng / ml). In the high adiponectin group, the mean age (p=0.001) and high-density lipoprotein (HDL) cholesterol (p=0.015) were higher, whereas estimated glomerular filtration rate (eGFR) (p=0.036) and hemoglobin (p=0.014) levels were lower. Although LA maximum volume, LA minimum volume, and LA pre-A volume were higher in the group with high adiponectin levels, they did not reach a statistical significance. Peak early diastolic LA strain (S-LAe) (p=0.048) and strain rate (SR-LAe) (p=0.017) were lower in this group. Multivariate logistic regression analysis demonstrated that age (p=0.003) and hemoglobin (p=0.006) were predictors of elevated adiponectin levels. On the contrary, S-LAe, HDL cholesterol, and eGFR lost their statistical significance.
Conclusion    In patients with HT and DM, elevated adiponectin level is associated with impaired LA mechanical functions. Increased age and hemoglobin level are independent predictors of elevated adiponectin levels.

1.

2. Yamaguchi N, Okumura Y, Watanabe I, Nagashima K, Takahashi K, Iso K et al. Clinical implications of serum adiponectin on progression of atrial fibrillation. Journal of Arrhythmia. 2017;33(6):608–12. DOI: 10.1016/j.joa.2017.07.009

3. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and Risk of Coronary Heart Disease in Older Men and Women. The Journal of Clinical Endocrinology & Metabolism. 2008;93(9):3357–64. DOI:10.1210/jc.2008-0640

4. Karas MG, Benkeser D, Arnold AM, Bartz TM, Djousse L, Mukamal KJ et al. Relations of Plasma Total and High-Molecular-Weight Adiponectin to New-Onset Heart Failure in Adults ≥65 Years of Age (from the Cardiovascular Health Study). The American Journal of Cardiology. 2014;113(2):328–34. DOI: 10.1016/j.amjcard.2013.09.027

5. Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ et al. Associations of total and high-molecular-weight adiponectin with allcause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation. 2012;126(25):2951–61. DOI: 10.1161/CIRCULATIONAHA.112.135202

6. Guo Y, Liu L, Wang J. Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. Bioscience Reports. 2019;39(6):BSR20182284. DOI: 10.1042/BSR20182284

7. Hao G, Li W, Guo R, Yang J-G, Wang Y, Tian Y et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: A meta-analysis of 17 prospective studies. Atherosclerosis. 2013;228(1):29–35. DOI: 10.1016/j.atherosclerosis.2013.02.018

8. Thomas L, Abhayaratna WP. Left Atrial Reverse Remodeling. JACC: Cardiovascular Imaging. 2017;10(1):65–77. DOI: 10.1016/j.jcmg.2016.11.003

9. Mondillo S, Cameli M, Caputo ML, Lisi M, Palmerini E, Padeletti M et al. Early detection of left atrial strain abnormalities by speckle-tracking in hypertensive and diabetic patients with normal left atrial size. Journal of the American Society of Echocardiography. 2011;24(8):898–908. DOI: 10.1016/j.echo.2011.04.014

10. Kawakami H, Ramkumar S, Nolan M, Wright L, Yang H, Negishi K et al. Left Atrial Mechanical Dispersion Assessed by Strain Echocardiography as an Independent Predictor of New-Onset Atrial Fibrillation: A Case-Control Study. Journal of the American Society of Echocardiography. 2019;32(10):1268-1276.e3. DOI: 10.1016/j.echo.2019.06.002

11. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP et al. Incidence of and Risk Factors for Atrial Fibrillation in Older Adults. Circulation. 1997;96(7):2455–61. DOI: 10.1161/01.CIR.96.7.2455

12. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. American Journal of Kidney Diseases. 2007;50(6):927–37. DOI: 10.1053/j.ajkd.2007.09.004

13. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. Journal of the American Society of Echocardiography. 2004;17(10):1086–119. DOI: 10.1016/j.echo.2004.07.013

14. Macheret F, Bartz TM, Djousse L, Ix JH, Mukamal KJ, Zieman SJ et al. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart. 2015;101(17):1368–74. DOI: 10.1136/heartjnl-2014-307015

15. Kim T-H, Lee JS, Uhm J-S, Joung B, Lee M-H, Pak H-N. High circulating adiponectin level is associated with poor clinical outcome after catheter ablation for paroxysmal atrial fibrillation. EP Europace. 2018;20(8):1287–93. DOI: 10.1093/europace/eux173

16. Piñeiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, Rubio J et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Letters. 2005;579(23):5163–9. DOI: 10.1016/j.febslet.2005.07.098

17. Gualillo O, González-Juanatey JR, Lago F. The Emerging Role of Adipokines as Mediators of Cardiovascular Function: Physiologic and Clinical Perspectives. Trends in Cardiovascular Medicine. 2007;17(8):275–83. DOI: 10.1016/j.tcm.2007.09.005

18. Ybarra J, Resmini E, Planas F, Navarro-López F, Webb S, Pou JM et al. Relationship Between Adiponectin and Left Atrium Size in Uncomplicated Obese Patients: Adiponectin, a Link Between Fat and Heart. Obesity Surgery. 2009;19(9):1324–32. DOI: 10.1007/s11695-009-9924-5

19. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. Journal of Molecular and Cellular Cardiology. 2007;42(6):1065–74. DOI: 10.1016/j.yjmcc.2007.03.808

20. Ouchi N, Walsh K. A Novel Role for Adiponectin in the Regulation of Inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(7):1219–21. DOI: 10.1161/ATVBAHA.108.165068